Secarna Pharmaceuticals is the next generation antisense oligonucleotide (ASO) company addressing high unmet medical needs in the areas of immuno-oncology and immunology, as well as viral, neurodegenerative and cardiometabolic diseases. Secarna’s mission is to maximize the performance and output of its proprietary LNAplus™ antisense oligonucleotide discovery platform, as well as to develop highly specific, safe, and efficacious best-in-class antisense therapies for challenging or currently undruggable targets. With over 15 development programs focusing on targets in indications where antisense-based approaches have clear benefits over other therapeutic modalities, Secarna is the leading European antisense drug discovery and development company.
View Top Employees from Secarna Pharmaceuticals| Website | https://www.secarna.com/ |
| Revenue | $6 million |
| Employees | 15 (12 on RocketReach) |
| Founded | 2015 |
| Address | 19a Am Klopferspitz, Planegg, Bavaria 82152, DE |
| Phone | +49 6421 9830050 |
| Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Secarna Pharmaceuticals employee's phone or email?
Secarna Pharmaceuticals Questions
The Secarna Pharmaceuticals annual revenue was $6 million in 2024.
Richard Klar is the Chief Research Officer of Secarna Pharmaceuticals.
12 people are employed at Secarna Pharmaceuticals.
Secarna Pharmaceuticals is based in Planegg, Bavaria.
The NAICS codes for Secarna Pharmaceuticals are [3254, 32541, 325, 32].
The SIC codes for Secarna Pharmaceuticals are [283, 28].
Top Secarna Pharmaceuticals Employees
-
55
-
2
-
1
Related Companies
